What happened
In early September 2026 the U.S. Food and Drug Administration issued a de novo classification for Powerful Medical’s Queen of Hearts algorithm, which reads 12-lead electrocardiograms to help triage chest-pain patients, including occlusion myocardial infarctions that lack classic ST-segment elevation. STAT reported the authorization on 11 September 2026. De novo classification is uncommon for AI devices and typically requires more clinical evidence than a 510(k). This is a regulatory authorization of a diagnostic aid, not a measured reduction in mortality. The underlying model is a specialized clinical ECG system, not a frontier language model.
